Salmonella engineered to express CD20-targeting antibodies and a drug-converting enzyme can eradicate human lymphomas
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Key Points: Salmonella is engineered to specifically infect tumor cells based on recognition of a tumor antigen by a bacterial-expressed antibody. Once inside, Salmonella can transfer cytotoxic cargos to destroy human tumors even in the absence of an adaptive immune response.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cancer immunoediting: from immunosurveillance to tumor escape
Dunn, G. P., Bruce, A. T., Ikeda, H., Old, L. J., & Schreiber, R. D. (2002) · Nature Immunology · doi:10.1038/ni1102-991 · Cited by 5,393
A Third-Generation Lentivirus Vector with a Conditional Packaging System
Dull, T., Zufferey, R., Kelly, M., Mandel, R. J., Nguyen, M., Trono, D., & Naldini, L. (1998) · Journal of Virology · doi:10.1128/jvi.72.11.8463-8471.1998 · Cited by 3,341
Engineering the perfect (bacterial) cancer therapy
Forbes, N. S. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2934 · Cited by 905 · cited 2×
“Indeed, a number of bacterial strains, including Clostridium, Bifidobacterium, and Salmonella, exhibit a remarkable tropism for tumors, indicating a therapeutic potential (reviewed by Forbes).(2) Although the precise mechanisms facilitating bacterial tumor colonization are unclear, both the leakiness of the tumor vasc…”
Background
Cited by
Tumour-targeting bacteria engineered to fight cancer
Zhou, S., Gravekamp, C., Bermudes, D., & Liu, K. (2018) · Nature Reviews Cancer · doi:10.1038/s41568-018-0070-z · Cited by 821
Nanobodies: Next Generation of Cancer Diagnostics and Therapeutics
Yang, E. Y., & Shah, K. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.01182 · Cited by 291
Ultrasound-controllable engineered bacteria for cancer immunotherapy
Abedi, M. H., Yao, M. S., Mittelstein, D. R., Bar-Zion, A., Swift, M. B., Lee-Gosselin, A., Barturen-Larrea, P., Buss, M. T., & Shapiro, M. G. (2022) · Nature Communications · doi:10.1038/s41467-022-29065-2 · Cited by 260
Tumor target amplification: Implications for nano drug delivery systems
Seidi, K., Neubauer, H. A., Moriggl, R., Jahanban-Esfahlan, R., & Javaheri, T. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.02.020 · Cited by 145
Recombinant expression of nanobodies and nanobody-derived immunoreagents
de Marco, A. (2020) · Protein Expression and Purification · doi:10.1016/j.pep.2020.105645 · Cited by 137
“Specifically, anti-CD20 nanobodies exposed on Salmonella cells increased their selective accumulation in CD-20 positive tumors [95] with consequent decreased growth of such solid tumors.”
Metadata
- Authors
- Massa, P. E., Paniccia, A., Monegal, A., de Marco, A., & Rescigno, M.
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 2013-08-01
- Volume
- 122
- Issue
- 5
- Pages
- 705-714
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- OpenAlex
- W1978337610
- Cited by
- 107
- References
- 3
- FWCI
- 4.99
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Salmonella engineered to express CD20-targeting antibodies and a drug-converting enzyme can eradicate human lymphomas. https://app.cochat.ai/papers/10.1182/blood-2012-12-474098
- The paper
- Massa, P. E., Paniccia, A., Monegal, A., de Marco, A., & Rescigno, M. (2013). Salmonella engineered to express CD20-targeting antibodies and a drug-converting enzyme can eradicate human lymphomas. Blood. https://doi.org/10.1182/blood-2012-12-474098
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.